Artikel ; Online: The latest advances in the pharmacological management of endometriosis.
Expert opinion on pharmacotherapy
2022 , Seite(n) 1–13
Abstract: Introduction: Endometriosis is a benign disease, characterized by a wide range of symptoms and different degrees of severity, which is why therapy should be individually adapted to the patient's needs. Over the years, a lot of research has gone into ... ...
Abstract | Introduction: Endometriosis is a benign disease, characterized by a wide range of symptoms and different degrees of severity, which is why therapy should be individually adapted to the patient's needs. Over the years, a lot of research has gone into finding new therapeutic approaches for this enigmatic disease. Areas covered: This review presents the latest advances in pharmacological management of endometriosis and is solely focused on studies published from 2010 to 2021. Expert opinion: Clinicians and researchers are constantly searching for new therapeutic strategies for endometriosis patients. As there are well-established treatments, however, any new medication should fulfill at least one of the three criteria: increased efficacy, comparable efficacy but a better safety profile, or treatments that have a lack of accompanying contraceptive effects that are seen in most endometriosis treatments. While some new substances show promising results, further studies are needed to demonstrate the fulfillment of one of the above-mentioned criteria. |
---|---|
Sprache | Englisch |
Erscheinungsdatum | 2022-03-01 |
Erscheinungsland | England |
Dokumenttyp | Journal Article |
ZDB-ID | 2001535-5 |
ISSN | 1744-7666 ; 1465-6566 |
ISSN (online) | 1744-7666 |
ISSN | 1465-6566 |
DOI | 10.1080/14656566.2022.2045274 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 5130: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.